05:57:02 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Goodness Growth Holdings Inc
Symbol GDNS
Shares Issued 86,721,030
Close 2022-11-21 C$ 0.49
Market Cap C$ 42,493,305
Recent Sedar Documents

Goodness Growth shareholders approve all matters at AGM

2022-11-21 16:51 ET - News Release

Dr. Kyle E. Kingsley reports

GOODNESS GROWTH HOLDINGS ANNOUNCES VOTING RESULTS OF ANNUAL AND GENERAL MEETING OF SHAREHOLDERS

Goodness Growth Holdings Inc. has released the voting results of its annual and general meeting of shareholders, which was held on Friday, Nov. 18, 2022.

At the meeting, the number of directors on the board of directors of the company for the ensuing year was fixed at seven by the shareholders and the following nominees for election as directors of the company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the meeting:

  • Dr. Kyle E. Kingsley;
  • Chelsea A. Grayson;
  • Ross M. Hussey;
  • Victor E. Mancebo;
  • Judd T. Nordquist;
  • Josh Rosen;
  • Amber H. Shimpa.

Shareholders also approved the reappointment of Davidson & Company LLP as auditor of the company for the ensuing year and the authorization of directors to fix their remuneration.

Full details of the foregoing are contained in the report of voting results for the meeting, which has been filed on SEDAR.

About Goodness Growth Holdings Inc.

Goodness Growth Holdings is a physician-led, science-focused holding company which mission is to bring the power of plants to the world. The company's operations consist primarily of its multistate cannabis company subsidiary, Vireo Health Inc., and its science and intellectual property incubator, Resurgent Biosciences Inc. The company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites; it distributes its products through its growing network of Green Goods, along with other retail locations and third party dispensaries. Its team of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the company is licensed to grow, process and/or distribute cannabis in five markets and operates 18 dispensaries across the United States.

© 2024 Canjex Publishing Ltd. All rights reserved.